Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950135-05-003306
Filing Date
2005-06-14
Accepted
2005-06-14 16:15:15
Documents
6
Period of Report
2005-03-31

Document Format Files

Seq Description Document Type Size
1 ALKERMES, INC. FORM 10-K b55366aie10vk.htm 10-K 897079
2 EX-21.1 SUBSIDIARIES OF THE REGISTRANT b55366aiexv21w1.htm EX-21.1 5082
3 EX-23.1 CONSENT OF DELOITTE & TOUCHE LLP b55366aiexv23w1.htm EX-23.1 2331
4 EX-31.1 RULE 13A-14(A)/15D-14(A) CERTIFICATION b55366aiexv31w1.htm EX-31.1 7424
5 EX-31.2 RULE 13A-14(A)/15D-14(A) CERTIFICATION b55366aiexv31w2.htm EX-31.2 7424
6 EX-32.1 SECTION 906 CERTIFICATION b55366aiexv32w1.htm EX-32.1 3984
  Complete submission text file 0000950135-05-003306.txt   924598
Mailing Address
Business Address 88 SIDNEY ST CAMBRIDGE MA 02139-4136 617-494-0171
ALKERMES INC (Filer) CIK: 0000874663 (see all company filings)

EIN.: 232472830 | State of Incorp.: PA | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 001-14131 | Film No.: 05895071
SIC: 2834 Pharmaceutical Preparations